CBD Oil/THC is the ANSWER. I am 48 years young and I have several pains and anxiety No more PHENOBARBITOL or DILANTIN 6 pills a day-Thanks to Dr Peter Hurt for their top quality highly efficient CBD oil. 1 drop under my tongue twice a day and the glaucoma go away. I will do everything within my power to educate people about CBD.Text/Call # (804) 537-0917
It’s important to remember, though, that these areas of study are still very new and in their early stages. This makes it hard to predict just how far their reach and impact will be. Combined with lifestyle and dietary changes, prescribed cannabinoid use will very likely be a pivotal intervention in the future of obesity and diabetes management and recovery.
Success stories like Oliver’s are everywhere, but there’s not a lot of data to back up those results. That’s because CBD comes from cannabis and, like nearly all other parts of the plant, is categorized by the Drug Enforcement Agency (DEA) as a Schedule 1 drug—the most restrictive classification. (Others on that list: heroin, Ecstasy, and peyote.) This classification, which cannabis advocates have tried for years to change, keeps cannabis-derived products, including CBD, from being properly studied in the U.S.
Scam CBD sellers tend to manufacture low-grade oils via ethanol (or other solvent-based) extraction, in what is little better than trying to do it yourself in your basement. The result is a liquid that contains a little CBD (along with some other cannabinoids and terpenes), but not in the quantities needed to be effective in terms of any legitimate medicinal function. Moreover, these solvent-based extracts can contain unnecessary and potentially harmful components — after all, scam artists are not going to reveal the REAL ingredients, are they?
Even as we witness the unrelenting growth of the hemp and cannabis markets across the U.S., most legal aspects of the industry continue to be shrouded in veritable shades of gray. Federal lawmakers remain stubborn in removing cannabidiol (CBD) from the DEA’s list of Controlled Substances, even though the compound has recently been approved by the FDA to treat two rare forms of epilepsy.